Recurrent Hepatocellular Carcinoma: Percutaneous Radiofrequency Ablation after Hepatectomy-Reference-Cited by-同舟云学术

Recurrent Hepatocellular Carcinoma: Percutaneous Radiofrequency Ablation after Hepatectomy

Published:2004-01 Issue:1 Volume:230 Page:135-141
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Choi Dongil,Lim Hyo K.,Kim Min Ju,Lee Sung Hoon,Kim Seung Hoon,Lee Won Jae,Lim Jae Hoon,Joh Jae-Won,Kim Yong Il

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2301021182

Reference34 articles.

1. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

2. Shuto T, Kinoshita H, Hirohashi K, et al.Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma.Hepatogastroenterology1996; 43:932-937.

3. Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma

4. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma

5. Suenaga M, Sugiura H, Kokuba Y, Uehara S, Kurumiya T.Repeated hepatic resection for recurrent hepatocellular carcinoma in 18 cases.Surgery1994; 115:452-457.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study;International Journal of Hyperthermia;2022-01-18

2. Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome and Risk Signature Analysis;Frontiers in Oncology;2021-06-04

3. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis;BMC Gastroenterology;2020-11-27

4. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection;European Journal of Surgical Oncology;2020-08

5. Ablative therapies for hepatic and biliary tumors: endohepatology coming of age;Translational Gastroenterology and Hepatology;2020-04